Name: Global IVD Infectious Diseases Market Insights, Forecast to 2035
Brand: Extent Research
Price: 3500 USD
Availability: InStock
Rating: 4.8 (218 reviews)

Global IVD Infectious Diseases Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

The global IVD Infectious Diseases Market study covers all the microscopic and macroscopic market data that influences the market growth rate over the forecast period. The evaluated market size, share, volume, and revenue details of the market are also provided in this research study. Various research methodologies and primary or secondary resources are used to calculate and authenticate the market valuation of the IVD Infectious Diseases market. Furthermore, the future market scenario would provide clear picture of the market status and market revenue from the market growth point of view. Authentic information gathering techniques have helped gather all the market statistical and theoretical data and be represented in the graphical, tabular, pie or bar chart, and other pictorial form.

Data provided by Extent Research. Source: https://www.extentresearch.com/ivd-infectious-diseases-market

The report also analyzes the market players in the global IVD Infectious Diseases market according to the market revenue, production footprint, growth rate, and demand. The key market players mentioned in the report include BD, BioMerieux, Abbott, Quidel, Gen-Probe, Abbott, Danaher, Sysmex, Orasure, Hologic, Cepheid, Qiagen, Roche Diagnostics, Siemens Healthcare, Bio-Rad Laboratories, . The research study also covers all the market opportunities, threats, challenges, growth influencers, and weaknesses.

Segmentation of the Global IVD Infectious Diseases Market:

By Product type

Immunochemistry, Molecular Diagnostics,

by Application

Clinical Laboratories, Diagnostic Centers,

Similarly, the report also offers details of the market-oriented regions including North America, Europe, Asia Pacific, Latin America, Middle East & Africa. The regional distribution provide insights of the market attractiveness, consumer preference, sales analysis, and costing analysis that predict the IVD Infectious Diseases market size and volume.

Queries answered in the global IVD Infectious Diseases market report:

What is the expected market growth rate during the forecast period?
Which are the regions expected to show market growth and why?
What are the significant market growth factors?
Which are market players dominate the global IVD Infectious Diseases market?

Key data covered in the global IVD Infectious Diseases report:

Breakdown data structure of the global IVD Infectious Diseases market at the global level
Revenue and growth of the IVD Infectious Diseases market on the regional level
Supply/demand chain, distribution channels, and product costing in the global IVD Infectious Diseases market
Scrutinized data of the IVD Infectious Diseases based on market share, volume, and size
Critical analysis of the regional and market players of the IVD Infectious Diseases market
Market trends, latest developments, and business strategies influencing the IVD Infectious Diseases market growth

Report Scope and Market Segmentation

ATTRIBUTES	Global IVD Infectious Diseases Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global IVD Infectious Diseases Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global IVD Infectious Diseases Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 Immunochemistry
        1.2.3 Molecular Diagnostics
    1.3 Market by Application
        1.3.1 Global IVD Infectious Diseases Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Clinical Laboratories
        1.3.3 Diagnostic Centers
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global IVD Infectious Diseases Market Perspective (2017-2035)
    2.2 IVD Infectious Diseases Growth Trends by Region
        2.2.1 IVD Infectious Diseases Market Size by Region: 2017 VS 2021 VS 2035
        2.2.2 IVD Infectious Diseases Historic Market Size by Region (2017-2022)
        2.2.3 IVD Infectious Diseases Forecasted Market Size by Region (2023-2035)
    2.3 IVD Infectious Diseases Market Dynamics
        2.3.1 IVD Infectious Diseases Industry Trends
        2.3.2 IVD Infectious Diseases Market Drivers
        2.3.3 IVD Infectious Diseases Market Challenges
        2.3.4 IVD Infectious Diseases Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top IVD Infectious Diseases Players by Revenue
        3.1.1 Global Top IVD Infectious Diseases Players by Revenue (2017-2022)
        3.1.2 Global IVD Infectious Diseases Revenue Market Share by Players (2017-2022)
    3.2 Global IVD Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by IVD Infectious Diseases Revenue
    3.4 Global IVD Infectious Diseases Market Concentration Ratio
        3.4.1 Global IVD Infectious Diseases Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by IVD Infectious Diseases Revenue in 2021
    3.5 IVD Infectious Diseases Key Players Head office and Area Served
    3.6 Key Players IVD Infectious Diseases Product Solution and Service
    3.7 Date of Enter into IVD Infectious Diseases Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 IVD Infectious Diseases Breakdown Data by Type
    4.1 Global IVD Infectious Diseases Historic Market Size by Type (2017-2022)
    4.2 Global IVD Infectious Diseases Forecasted Market Size by Type (2023-2035)
5 IVD Infectious Diseases Breakdown Data by Application
    5.1 Global IVD Infectious Diseases Historic Market Size by Application (2017-2022)
    5.2 Global IVD Infectious Diseases Forecasted Market Size by Application (2023-2035)
6 North America
    6.1 North America IVD Infectious Diseases Market Size (2017-2035)
    6.2 North America IVD Infectious Diseases Market Size by Type
        6.2.1 North America IVD Infectious Diseases Market Size by Type (2017-2022)
        6.2.2 North America IVD Infectious Diseases Market Size by Type (2023-2035)
        6.2.3 North America IVD Infectious Diseases Market Share by Type (2017-2035)
    6.3 North America IVD Infectious Diseases Market Size by Application
        6.3.1 North America IVD Infectious Diseases Market Size by Application (2017-2022)
        6.3.2 North America IVD Infectious Diseases Market Size by Application (2023-2035)
        6.3.3 North America IVD Infectious Diseases Market Share by Application (2017-2035)
    6.4 North America IVD Infectious Diseases Market Size by Country
        6.4.1 North America IVD Infectious Diseases Market Size by Country (2017-2022)
        6.4.2 North America IVD Infectious Diseases Market Size by Country (2023-2035)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe IVD Infectious Diseases Market Size (2017-2035)
    7.2 Europe IVD Infectious Diseases Market Size by Type
        7.2.1 Europe IVD Infectious Diseases Market Size by Type (2017-2022)
        7.2.2 Europe IVD Infectious Diseases Market Size by Type (2023-2035)
        7.2.3 Europe IVD Infectious Diseases Market Share by Type (2017-2035)
    7.3 Europe IVD Infectious Diseases Market Size by Application
        7.3.1 Europe IVD Infectious Diseases Market Size by Application (2017-2022)
        7.3.2 Europe IVD Infectious Diseases Market Size by Application (2023-2035)
        7.3.3 Europe IVD Infectious Diseases Market Share by Application (2017-2035)
    7.4 Europe IVD Infectious Diseases Market Size by Country
        7.4.1 Europe IVD Infectious Diseases Market Size by Country (2017-2022)
        7.4.2 Europe IVD Infectious Diseases Market Size by Country (2023-2035)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific IVD Infectious Diseases Market Size (2017-2035)
    8.2 Asia-Pacific IVD Infectious Diseases Market Size by Type
        8.2.1 Asia-Pacific IVD Infectious Diseases Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific IVD Infectious Diseases Market Size by Type (2023-2035)
        8.2.3 Asia-Pacific IVD Infectious Diseases Market Share by Type (2017-2035)
    8.3 Asia-Pacific IVD Infectious Diseases Market Size by Application
        8.3.1 Asia-Pacific IVD Infectious Diseases Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific IVD Infectious Diseases Market Size by Application (2023-2035)
        8.3.3 Asia-Pacific IVD Infectious Diseases Market Share by Application (2017-2035)
    8.4 Asia-Pacific IVD Infectious Diseases Market Size by Region
        8.4.1 Asia-Pacific IVD Infectious Diseases Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific IVD Infectious Diseases Market Size by Region (2023-2035)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America IVD Infectious Diseases Market Size (2017-2035)
    9.2 Latin America IVD Infectious Diseases Market Size by Type
        9.2.1 Latin America IVD Infectious Diseases Market Size by Type (2017-2022)
        9.2.2 Latin America IVD Infectious Diseases Market Size by Type (2023-2035)
        9.2.3 Latin America IVD Infectious Diseases Market Share by Type (2017-2035)
    9.3 Latin America IVD Infectious Diseases Market Size by Application
        9.3.1 Latin America IVD Infectious Diseases Market Size by Application (2017-2022)
        9.3.2 Latin America IVD Infectious Diseases Market Size by Application (2023-2035)
        9.3.3 Latin America IVD Infectious Diseases Market Share by Application (2017-2035)
    9.4 Latin America IVD Infectious Diseases Market Size by Country
        9.4.1 Latin America IVD Infectious Diseases Market Size by Country (2017-2022)
        9.4.2 Latin America IVD Infectious Diseases Market Size by Country (2023-2035)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa IVD Infectious Diseases Market Size (2017-2035)
    10.2 Middle East & Africa IVD Infectious Diseases Market Size by Type
        10.2.1 Middle East & Africa IVD Infectious Diseases Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa IVD Infectious Diseases Market Size by Type (2023-2035)
        10.2.3 Middle East & Africa IVD Infectious Diseases Market Share by Type (2017-2035)
    10.3 Middle East & Africa IVD Infectious Diseases Market Size by Application
        10.3.1 Middle East & Africa IVD Infectious Diseases Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa IVD Infectious Diseases Market Size by Application (2023-2035)
        10.3.3 Middle East & Africa IVD Infectious Diseases Market Share by Application (2017-2035)
    10.4 Middle East & Africa IVD Infectious Diseases Market Size by Country
        10.4.1 Middle East & Africa IVD Infectious Diseases Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa IVD Infectious Diseases Market Size by Country (2023-2035)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 BD
        11.1.1 BD Company Details
        11.1.2 BD Business Overview
        11.1.3 BD IVD Infectious Diseases Introduction
        11.1.4 BD Revenue in IVD Infectious Diseases Business (2017-2022)
        11.1.5 BD Recent Developments
    11.2 BioMerieux
        11.2.1 BioMerieux Company Details
        11.2.2 BioMerieux Business Overview
        11.2.3 BioMerieux IVD Infectious Diseases Introduction
        11.2.4 BioMerieux Revenue in IVD Infectious Diseases Business (2017-2022)
        11.2.5 BioMerieux Recent Developments
    11.3 Abbott
        11.3.1 Abbott Company Details
        11.3.2 Abbott Business Overview
        11.3.3 Abbott IVD Infectious Diseases Introduction
        11.3.4 Abbott Revenue in IVD Infectious Diseases Business (2017-2022)
        11.3.5 Abbott Recent Developments
    11.4 Quidel
        11.4.1 Quidel Company Details
        11.4.2 Quidel Business Overview
        11.4.3 Quidel IVD Infectious Diseases Introduction
        11.4.4 Quidel Revenue in IVD Infectious Diseases Business (2017-2022)
        11.4.5 Quidel Recent Developments
    11.5 Gen-Probe
        11.5.1 Gen-Probe Company Details
        11.5.2 Gen-Probe Business Overview
        11.5.3 Gen-Probe IVD Infectious Diseases Introduction
        11.5.4 Gen-Probe Revenue in IVD Infectious Diseases Business (2017-2022)
        11.5.5 Gen-Probe Recent Developments
    11.6 Abbott
        11.6.1 Abbott Company Details
        11.6.2 Abbott Business Overview
        11.6.3 Abbott IVD Infectious Diseases Introduction
        11.6.4 Abbott Revenue in IVD Infectious Diseases Business (2017-2022)
        11.6.5 Abbott Recent Developments
    11.7 Danaher
        11.7.1 Danaher Company Details
        11.7.2 Danaher Business Overview
        11.7.3 Danaher IVD Infectious Diseases Introduction
        11.7.4 Danaher Revenue in IVD Infectious Diseases Business (2017-2022)
        11.7.5 Danaher Recent Developments
    11.8 Sysmex
        11.8.1 Sysmex Company Details
        11.8.2 Sysmex Business Overview
        11.8.3 Sysmex IVD Infectious Diseases Introduction
        11.8.4 Sysmex Revenue in IVD Infectious Diseases Business (2017-2022)
        11.8.5 Sysmex Recent Developments
    11.9 Orasure
        11.9.1 Orasure Company Details
        11.9.2 Orasure Business Overview
        11.9.3 Orasure IVD Infectious Diseases Introduction
        11.9.4 Orasure Revenue in IVD Infectious Diseases Business (2017-2022)
        11.9.5 Orasure Recent Developments
    11.10 Hologic
        11.10.1 Hologic Company Details
        11.10.2 Hologic Business Overview
        11.10.3 Hologic IVD Infectious Diseases Introduction
        11.10.4 Hologic Revenue in IVD Infectious Diseases Business (2017-2022)
        11.10.5 Hologic Recent Developments
    11.11 Cepheid
        11.11.1 Cepheid Company Details
        11.11.2 Cepheid Business Overview
        11.11.3 Cepheid IVD Infectious Diseases Introduction
        11.11.4 Cepheid Revenue in IVD Infectious Diseases Business (2017-2022)
        11.11.5 Cepheid Recent Developments
    11.12 Qiagen
        11.12.1 Qiagen Company Details
        11.12.2 Qiagen Business Overview
        11.12.3 Qiagen IVD Infectious Diseases Introduction
        11.12.4 Qiagen Revenue in IVD Infectious Diseases Business (2017-2022)
        11.12.5 Qiagen Recent Developments
    11.13 Roche Diagnostics
        11.13.1 Roche Diagnostics Company Details
        11.13.2 Roche Diagnostics Business Overview
        11.13.3 Roche Diagnostics IVD Infectious Diseases Introduction
        11.13.4 Roche Diagnostics Revenue in IVD Infectious Diseases Business (2017-2022)
        11.13.5 Roche Diagnostics Recent Developments
    11.14 Siemens Healthcare
        11.14.1 Siemens Healthcare Company Details
        11.14.2 Siemens Healthcare Business Overview
        11.14.3 Siemens Healthcare IVD Infectious Diseases Introduction
        11.14.4 Siemens Healthcare Revenue in IVD Infectious Diseases Business (2017-2022)
        11.14.5 Siemens Healthcare Recent Developments
    11.15 Bio-Rad Laboratories
        11.15.1 Bio-Rad Laboratories Company Details
        11.15.2 Bio-Rad Laboratories Business Overview
        11.15.3 Bio-Rad Laboratories IVD Infectious Diseases Introduction
        11.15.4 Bio-Rad Laboratories Revenue in IVD Infectious Diseases Business (2017-2022)
        11.15.5 Bio-Rad Laboratories Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global IVD Infectious Diseases Market